SARS-CoV-2 Variants and Mutational Patterns: Relationship with Risk of Ventilator-associated Pneumonia in Critically Ill COVID-19 Patients in the Era of Dexamethasone
Authors
Affiliations
We aimed to explore the relationships between specific viral mutations/mutational patterns and ventilator-associated pneumonia (VAP) occurrence in COVID-19 patients admitted in intensive care units between October 1, 2020, and May 30, 2021. Full-length SARS-CoV-2 genomes were sequenced by means of next-generation sequencing. In this prospective multicentre cohort study, 259 patients were included. 222 patients (47%) had been infected with pre-existing ancestral variants, 116 (45%) with variant α, and 21 (8%) with other variants. 153 patients (59%) developed at least one VAP. There was no significant relationship between VAP occurrence and a specific SARS CoV-2 lineage/sublineage or mutational pattern.
Sciurti A, Baccolini V, Ceparano M, Isonne C, Migliara G, Iera J Antibiotics (Basel). 2024; 13(9).
PMID: 39335015 PMC: 11428387. DOI: 10.3390/antibiotics13090842.
Bacterial co-infection in COVID-19: a call to stay vigilant.
Liu S, Yu C, Tu Q, Zhang Q, Fu Z, Huang Y PeerJ. 2024; 12:e18041.
PMID: 39308818 PMC: 11416760. DOI: 10.7717/peerj.18041.